EUVIMEDEUVIMED entdecken
Crossref

An esterase-activated celastrol delivery system suppressed steatosis-related hepatocellular carcinoma progression

Zile Shao, Yangla Xie, Yidan Shen, Yiyang Sun, Long Zhang, Nasha Qiu, Xiao Xu

Biomaterials Science · 2026 · 14 (15) · 3982-3994

DOI: 10.1039/d6bm00447d ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomaterials Science, 2026. Verfasst von Zile Shao und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou First People's Hospital, Hangzhou 310053, China. qiunasha@zju.e…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Pentacyclic Triterpenes, Fatty Liver. Die Arbeit nennt 30 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Key Research and Development Program of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Schematic illustration of intratumorally delivered PQDMA@CEL NPs, triggering HCC ferroptosis and degrading lipids, and further remodeling immunosuppressive microenvironment and enhancing anti-tumor efficacy in Hepa1-6 bilateral tumor models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsPentacyclic TriterpenesFatty LiverEsterasesAntineoplastic AgentsTriterpenesHumansAnimalsMiceCell Line, TumorDrug Delivery SystemsDisease ProgressionNanoparticles

Substanzen

celastrolPentacyclic TriterpenesEsterasesAntineoplastic AgentsTriterpenes

Autor:innen und Institutionen

  • The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou First People's Hospital, Hangzhou 310053, China. qiunasha@zju.edu.cn.
  • Key Laboratory of Integrated Oncology and Intelligent Medicine of Zhejiang Province, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou 310006, China.
  • Zhejiang University School of Medicine, Hangzhou 310058, China.
  • Hangzhou Normal University, Hangzhou 311121, China.
  • Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210000, China.

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Key Research and Development Program of Zhejiang Province

Zitieren

APA

Shao, Z., Xie, Y., Shen, Y., Sun, Y., Zhang, L., Qiu, N., & Xu, X. (2026). An esterase-activated celastrol delivery system suppressed steatosis-related hepatocellular carcinoma progression. Biomaterials Science, 14(15), 3982-3994. https://doi.org/10.1039/d6bm00447d

Vancouver

Shao Z, Xie Y, Shen Y, Sun Y, Zhang L, Qiu N, et al. An esterase-activated celastrol delivery system suppressed steatosis-related hepatocellular carcinoma progression. Biomaterials Science. 2026;14(15):3982-3994. doi:10.1039/d6bm00447d

BibTeX
@article{Shao2026,
  author = {Shao, Zile and Xie, Yangla and Shen, Yidan and Sun, Yiyang and Zhang, Long and Qiu, Nasha and Xu, Xiao},
  title = {An esterase-activated celastrol delivery system suppressed steatosis-related hepatocellular carcinoma progression},
  journal = {Biomaterials Science},
  year = {2026},
  volume = {14},
  number = {15},
  pages = {3982--3994},
  doi = {10.1039/d6bm00447d}
}
Kostenlos starten →